发明名称 |
Methods Of Selectively Treating Asthma Using IL-13 Antagonists |
摘要 |
The disclosure is directed to novel predictive methods and personalized therapies for treating asthma. Specifically, this disclosure relates to methods of treating a patient having asthma by selectively administering an IL-13 antagonist, on the basis of that patient being genetically predisposed to have a favorable response to treatment with the IL-13 antagonist. Also disclosed herein are transmittable forms of information, diagnostic methods, and kits useful in predicting the likelihood that a patient having asthma will respond to treatment with an IL-13 antagonist. |
申请公布号 |
US2017029894(A1) |
申请公布日期 |
2017.02.02 |
申请号 |
US201515302348 |
申请日期 |
2015.04.08 |
申请人 |
Damask Amy;Lewitzky Steven;Rotte Michael |
发明人 |
Damask Amy;Lewitzky Steven;Rotte Michael |
分类号 |
C12Q1/68;C07K16/24 |
主分类号 |
C12Q1/68 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of selectively treating a patient having asthma, comprising
i) identifying a patient having at least one AIR marker selected from the group consisting of AIR marker-1, 2, 3, 4, 5, 6, 7, 8, and 9, and ii) thereafter administering a therapeutically effective amount of an IL-13 antagonist to the patient. |
地址 |
Somerville MA US |